Table 2. Bone mineral density and marrow adipose tissue of study subjects.
Non-T2DM | T2DM | p | |
---|---|---|---|
DXA (g/cm2) | |||
Spine aBMD | 1.1 ± 0.1 | 1.2 ± 0.2 | 0.3 |
Total Hip aBMD | 1.1 ± 0.1 | 1.1 ± 0.2 | 0.8 |
Femoral Neck aBMD | 0.9 ± 0.1 | 1.0 ± 0.2 | 0.6 |
QCT (mg/cm3) | |||
Spine vBMD | 166 ± 33 | 172 ± 37 | 0.7 |
Total Hip vBMD | 360 ± 43 | 374 ± 45 | 0.4 |
Femoral Neck vBMD | 357 ± 52 | 404 ± 55 | 0.02 |
Marrow Adipose Tissue (lipids/water) | |||
L1-L2 | 0.64 ± 0.3 | 0.93 ± 0.3 | 0.03 |
Femoral Metaphysis | 2.4 ± 0.9 | 4.0 ± 2.6 | 0.04 |
Femoral Diaphysis | 3.2 ± 1.9 | 2.7 ± 0.9 | 1.0 |
Marrow Adipose Tissue (unsaturation index) |
|||
L1-L2 | 0.08 ± 0.03 | 0.1 ± 0.02 | 0.9 |
Femoral Metaphysis | 0.06 ± 0.01 | 0.06 ± 0.02 | 0.9 |
Femoral Diaphysis | 0.07 ± 0.01 | 0.06 ± 0.001 | 0.03 |
DXA: dual-energy x-ray absorptiometry; QCT: quantitative computed tomography; aBMD: areal bone mineral density; vBMD: volumetric bone mineral density